Park Avenue Securities LLC Abiomed Inc Transaction History

Park Avenue Securities LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$242.49 - $301.46 $26,916 - $33,462	-111 Reduced 2.61%	4,134 $1.02 Million
Q2 2022 Jul 27, 2022	BUY	$224.73 - $338.64 $103,375 - $155,774	460 Added 12.15%	4,245 $1.05 Million
Q1 2022 Apr 29, 2022	BUY	$277.25 - $366.29 $866,960 - $1.15 Million	3,127 Added 475.23%	3,785 $1.25 Million
Q4 2021 Apr 08, 2022	BUY	$300.63 - $371.35 $10,221 - $12,625	34 Added 5.45%	658 $236,000
Q3 2021 Oct 21, 2021	BUY	$310.19 - $376.2 $193,558 - $234,748	624 New	624 $203,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.